G8 Education Ltd (GEM)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 0.088 |
|---|---|
| 52-week range | 0.088 – 0.853 |
| Return, 1 month / 3 months | −10.2% / −34.8% |
| Return, 1 year / 3 years | −89.4% / −91.3% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 78.4% |
| Worst drawdown (1 year) | -89.5% |
| Average daily value traded | 0.52M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
G8 Education is an Australian provider of early childhood education and childcare services. It operates a network of childcare centres across the country, offering care and preschool programs for young children. Its centres trade under a range of local brand names, and families pay fees that are often partly covered by government childcare support. The company is based in Australia and serves parents and communities through its centres.
G8 Education Ltd trades under the code GEM on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
G8 Education Ltd (GEM) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.088 on 22 October 2026.
Its price-based Market X-Ray is 21 out of 100 (a weak price profile), ranking 1,607 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 89.4% and over the last three months it fell 34.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 2 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -62.2% | ||
| From 52-week high | -89.6% | ||
| Momentum | 5 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -34.8% | ||
| 6-month return | -64.8% | ||
| 12-month return, skipping the last month | -88.2% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 78.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -89.5% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 0.52M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −10.2% |
| 3 months | −34.8% |
| 6 months | −64.8% |
| 1 year | −89.4% |
| 3 years | −91.3% |
| 5 years | −90.8% |
Signals
| 50-day / 200-day average | 0.113 / 0.233 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.005 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Sep 2025 | AUD 0.0200 |
| 6 Mar 2025 | AUD 0.0350 |
| 6 Sep 2024 | AUD 0.0200 |
| 7 Mar 2024 | AUD 0.0300 |
| 7 Sep 2023 | AUD 0.0150 |
| 9 Mar 2023 | AUD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.